Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
Completed · Phase 3
Conditions studied: Anorexia, Cachexia, Lung Cancer
In brief
RATIONALE: Megestrol helps improve appetite. It is not yet known if megestrol is effective in limiting weight loss in patients who are undergoing radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of megestrol in limiting weight loss in patients who are undergoing radiation therapy for lung cancer.
Key facts
- Study ID
- NCT00031785
- Run by
- Wake Forest University Health Sciences
- People needed
- 25
- Starts
- 2000-09-01
- Expected to finish
- 2002-09-11
- Last updated by the study team
- 2021-09-09
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Comprehensive Cancer Center at Wake Forest University — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.